The fact that NI antibodies acquired after infection or prior vaccination demonstrate a broad spectrum associated with a reduction in the likelihood of influenza disease supports the inclusion of NA in next-generation vaccines aimed at better protection against drift variants [15,16]. Here, XK is linked to infection.